Browse Recombinant DNA topic

Subtopics (7)

• Genetic aspects
• Health aspects
• Intellectual property
• Research
• Safety and security measures
• Study and teaching
• Usage

Articles

Title	Author	Type	Date	Words
Molecular epidemiology of feline and human Bartonella henselae isolates.	Bouchouicha, Rim; Durand, Benoit; Monteil, Martine; Chomel, B.B.; Berrich, Moez; Arvand, Mardjan; Bi		May 1, 2009	2774
Emergence of Francisella novicida bacteremia, Thailand.	Leelaporn, Amornrut; Yongyod, Samaporn; Limsrivanichakorn, Sunee; Yungyuen, Thitiya; Kiratisin, Patt		Dec 1, 2008	1951
Immunizing antigens and constituents of vaccines/Bagisiklik antijenleri ve asi icerigi.	Keser, Melike; Hatipoglu, Nevin		Sep 1, 2008	5836
Identification of larval sea basses (Centropristis spp.) using ribosomal DNA-specific molecular assays.	Vandersea, Mark W.; Litaker, R. Wayne; Marancik, Katrin E.; Hare, Jonathan A.; Walsh, Harvey J.; Lem	Report	Apr 1, 2008	6767
Tercica Initiates Phase II Clinical Trial with Next-Generation Growth Hormone Product for the Treatment of Short Stature.			Jan 22, 2008	814
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute obtains United States patent.			Jan 1, 2008	136
Hollis-Eden Pharmaceuticals Commencing Phase I/II Clinical Trial with TRIOLEX(TM) (HE3286) in Obese, Insulin Resistant Volunteers.			Oct 16, 2007	1138
Paratus Delivers Medicines to War-Ravaged Kirkuk.			Oct 9, 2007	592
High Growth Forecasted in the External Insulin Pumps Industry.			Oct 2, 2007	351
[gamma]H2AX and its role in DNA double-strand break repair (1).	Fillingham, Jeffrey; Keogh, Michael-Christopher; Krogan, Nevan J.		Aug 1, 2006	8369
Invasive genes: humans incorporate DNA from parasite.	Lock, C.		Jul 31, 2004	526
Rockefeller University obtains United States patent.		Brief Article	Apr 1, 2004	165
Suntory obtains United States patent.		Brief Article	Apr 1, 2004	81
North Carolina State University obtains United States patent.		Brief Article	Feb 1, 2004	64
Symphogen obtains European patent for methods to produce recombinant polyclonal antibodies.			Jun 1, 2003	471
Ambion licenses RNA interference technology from MIT.		Brief Article	Mar 1, 2002	226
Amano Pharmaceutical obtains United States patent.		Brief Article	Oct 1, 2001	70
A COLLABORATIVE RECOMBINANT DNA TECHNOLOGY COURSE WITH LABORATORY.		Brief Article	Apr 1, 2001	178
Whatman Purchases Invitrogen Business.			Feb 28, 2001	90
Patent awarded to Biomed for homeopathic recombinant human growth hormone.			Feb 1, 2001	313
Transkaryotic receives patent for gene targeting technology.			Feb 1, 2001	369
Estonian parliament passes law creating world's largest gene bank.		Brief Article	Jan 16, 2001	184
Akkadix acquires exclusive license to Pangene's enhanced homologous recombination technologies for plant science applications.		Brief Article	Sep 1, 2000	663
Nature Technology obtains United States patent.		Brief Article	Sep 1, 2000	56
University of Wisconsin applies for patent.		Brief Article	Sep 1, 2000	38
Maxygen applies for patent.		Brief Article	Jun 1, 2000	43
AdVec obtains United States patent.		Brief Article	Jan 1, 2000	31
Principia Pharmaceutical formed to develop therapeutic proteins with prolonged activity.			Aug 1, 1999	442
Phytomedics announces allowance of a United States patent for transgenic plant recombinant protein technology.			Jun 1, 1999	385
Novo Nordisk obtains United States patent.			Mar 1, 1999	72
Limagrain Genetics Corp. Announces Its Intention to Cash Out the Public Stockholders of BioTechnica International, Inc.			Sep 21, 1998	358
Genetic MicroSystems Inc. and Takara Shuzo Co., Ltd. Sign Distribution Agreement For DNA Microarray Products.		Article	Sep 10, 1998	328
Human Medical Options (Latin America) S.A. Panama Makes Announcement.		Article	Aug 25, 1998	333
CSI Researchers Express ssDNA in HeLa Cells.		Article	Aug 4, 1998	111
Agennix Receives U.S. Patent On Production of Recombinant Lactoferrin.		Article	Jul 13, 1998	267
CSI Researchers Express ssDNA in Vivo.		Article	Jul 6, 1998	182
Lynx to Use New Technology for Polymorphism Searches and Genotyping.		Article	Jun 16, 1998	233
ICOS Corp. announces Phase 2 clinical trial with human recombinant PAF-AH.			Jun 20, 1997	211
FDA clears Genentech's Nutropin AQ for use in Turner Syndrome Patients.			Apr 1, 1997	284
Protein Sciences Corporation appoints Dr. Bethanie E. Wilkinson Director, Business Development.			Feb 25, 1997	249
Covance begins manufacturing at biotech facility.			Jan 29, 1997	355
Somatogen announces second quarter results.			Jan 17, 1997	348
Francois Lebel, M.D., FRCPC joins GalaGen as Vice President of Scientific and Regulatory Affairs.			Jan 8, 1997	452
Novopharm Biotech Announces New Opportunities for Recombinant NOVOMAb-G2.			Nov 13, 1996	333
Somatogen announces first quarter results.			Oct 17, 1996	307
Somatogen files IND for recombinant hemoglobin as treatment for anemia.			Feb 20, 1996	229
FDA grants Genentech clearance to market Nutropin AQ.			Jan 3, 1996	125
Spinal Markets To Grow at 7 Percent Rate, Top $300 Million, Slowed By Regulatory, Legal Worries.			Jan 2, 1996	517
Astra Merck Inc. and Lexin Pharmaceutical Corporation announce agreement to test acute pancreatitis therapy; Astra Merck agrees to fund development.			Oct 30, 1995	660
Connective Therapeutics Completes Phase I Safety Trial of Relaxin for Scleroderma.			Aug 24, 1995	480
Bio-Technology General plans to appeal preliminary injunction in U.S. Court of Appeals.			Aug 11, 1995	282
Serono sponsors clinical trial to study safety and efficacy of mammalian cell-derived recombinant human growth hormone (r-hGH(m)) in children with HIV-associated "failure to thrive".			Mar 29, 1995	384
SOFAMOR DANEK AND GENETICS INSTITUTE ENTER INTO CORPORATE ARRANGEMENTS FOR COMMERCIALIZING BONE MORPHOGENETIC PROTEIN IN SPINAL RECONSTRUCTION.			Feb 17, 1995	573
NEUPOGEN (R) approved in Europe for peripheral cell support.			Jan 12, 1995	483
Genes may shuffle in developing brain.	Ezzell, Carol		Oct 5, 1991	607
Recombinant rodents, human hemoglobin.	Weiss, R.		Sep 2, 1989	543
Battling illness with body proteins; recombinant DNA technology has enabled medical researchers to manufacture several human proteins that can bolster the body's natural defenses against disease.	Murray, Mary		Jan 17, 1987	2702
Mummy DNA intact after 2,400 years.	Miller, Julie Ann		Apr 27, 1985	407
Lessons from Asilomar; ten years after the historic conference on the risks of gene-splicing research, scientists look back with a mixture of pride, disappointment and embarrassment.	Miller, Julie Ann		Feb 23, 1985	2326